Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Head Neck. 2009 Oct;31(10):1274-81. doi: 10.1002/hed.21090.

Genetic polymorphisms in the tobacco smoke carcinogens detoxifying enzyme UGT1A7 and the risk of head and neck cancer.

Author information

  • 1Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Maastricht, Maastricht, The Netherlands. martin.lacko@mumc.nl

Abstract

BACKGROUND:

UGT1A7 is an enzyme involved in the metabolism of (pre)carcinogens present in tobacco smoke. We investigated whether genetic polymorphisms in UGT1A7, with predicted altered enzyme activity, may have a risk-modifying effect on head and neck carcinogenesis.

METHODS:

Blood samples from 427 patients with oral, pharyngeal, and laryngeal carcinoma and 420 healthy control subjects were investigated for UGT1A7 polymorphisms. Based on these polymorphisms, patients and controls were divided according to predicted enzyme activity (low, intermediate, high).

RESULTS:

Logistic regression analysis showed a significant increased distribution of predicted high activity UGT1A7 polymorphisms among the patients (OR:1.44; 95% CI: 1.07-1.93). Stratified analyses demonstrated that high activity UGT1A7 polymorphisms were even more significantly present in patients with laryngeal cancer, older patients, heavy smokers, and heavy drinkers when compared with the control subjects.

CONCLUSIONS:

Predicted high activity UGT1A7 polymorphisms were significantly associated with an increased risk of head and neck cancer.

(c) 2009 Wiley Periodicals, Inc.

PMID:
19360737
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk